- BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp.
Website
Offer Price
Offer Size
3-Year Outlook
Volatility
1st Day Turnover
$4.00
1,300,000
Positive
High
201.91%
Offering Team
Deal Managers
- Network 1 Financial
Lawyers
- Ortoli Rosenstadt LLP
Auditors
- JP Centurion & Partners PLT
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
BioNexus Gene Lab Corp., through our wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Furthermore, the Company is also in the business of developing and providing safe, effective, and non-inv More
Deal Tracker
Investors
Filing
19 Jul, 2023Offer
20 Jul, 2023Look Ahead
Lock Up Expiry
20 Jan, 2024Earning
Nov 1, 2018IPO Terms
| Offer Price | $4.00 |
| Offer Size | 1M |